Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Rayner

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Advances in Therapy|November 8, 2011
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experienceJames R Smith, Craig R Rayner, Barbara Donner, et al.
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19Michael G Dodds, Eileen B Doyle, Angela M Reiersen, et al.
The Lancet. Global Health|August 24, 2020
Clinical trials of disease stages in COVID 19: complicated and often misinterpretedJay J H Park, Eric H Decloedt, Craig R Rayner, et al.
The Annals of Pharmacotherapy|June 15, 2006
Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitisLauren M Boak, Jian Li, Denis Spelman, et al.
Plos One|March 8, 2013
Assessing mathematical models of influenza infections using features of the immune responseHana M Dobrovolny, Micaela B Reddy, Mohamed A Kamal, et al.
Clinical Pharmacology in Drug Development|December 1, 2018
Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug DevelopmentThomas M Polasek, Craig R Rayner, Richard W Peck, et al.
Antiviral Therapy|May 28, 2015
Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trialBarbara A Rath, Jerzy Brzostek, Sara Guillén, et al.
The American Journal of Tropical Medicine and Hygiene|November 25, 2020
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19Zelyn Lee, Craig R Rayner, Jamie I Forrest, et al.
British Journal of Clinical Pharmacology|September 20, 2006
Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasmaSreeja Sudhakaran, Craig R Rayner, Jian Li, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairmentLeonid Gibiansky, Mylène Giraudon, Craig R Rayner, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Advances in Therapy|November 8, 2011
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experienceJames R Smith, Craig R Rayner, Barbara Donner, et al.
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19Michael G Dodds, Eileen B Doyle, Angela M Reiersen, et al.
The Lancet. Global Health|August 24, 2020
Clinical trials of disease stages in COVID 19: complicated and often misinterpretedJay J H Park, Eric H Decloedt, Craig R Rayner, et al.
The Annals of Pharmacotherapy|June 15, 2006
Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitisLauren M Boak, Jian Li, Denis Spelman, et al.
Plos One|March 8, 2013
Assessing mathematical models of influenza infections using features of the immune responseHana M Dobrovolny, Micaela B Reddy, Mohamed A Kamal, et al.
Clinical Pharmacology in Drug Development|December 1, 2018
Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug DevelopmentThomas M Polasek, Craig R Rayner, Richard W Peck, et al.
Antiviral Therapy|May 28, 2015
Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trialBarbara A Rath, Jerzy Brzostek, Sara Guillén, et al.
The American Journal of Tropical Medicine and Hygiene|November 25, 2020
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19Zelyn Lee, Craig R Rayner, Jamie I Forrest, et al.
British Journal of Clinical Pharmacology|September 20, 2006
Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasmaSreeja Sudhakaran, Craig R Rayner, Jian Li, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairmentLeonid Gibiansky, Mylène Giraudon, Craig R Rayner, et al.
Pageof 7